{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:20:29Z","timestamp":1775830829385,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.amjmed.2005.05.008","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T10:48:06Z","timestamp":1120301286000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S","title":["Rational antibiotic treatment of outpatient genitourinary infections in a changing environment"],"prefix":"10.1016","volume":"118","author":[{"given":"Richard D.","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.C.","family":"DeBlieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Press","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.05.008_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","article-title":"Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann Intern Med."},{"issue":"suppl","key":"10.1016\/j.amjmed.2005.05.008_bib2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med."},{"key":"10.1016\/j.amjmed.2005.05.008_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mda.2003.7","article-title":"Epidemiology of urinary tract infections","volume":"49","author":"Foxman","year":"2003","journal-title":"Dis Mon."},{"key":"10.1016\/j.amjmed.2005.05.008_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2005.05.008_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/46.suppl_1.1","article-title":"Pathogenesis of urinary tract infections","volume":"46","author":"Hooton","year":"2000","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.amjmed.2005.05.008_bib6","first-page":"43","article-title":"Urinary tract infections in healthy women","volume":"5","author":"Stapleton","year":"2003","journal-title":"Curr Treat Opt Infect Dis."},{"key":"10.1016\/j.amjmed.2005.05.008_bib7","first-page":"122","article-title":"Diagnosis and management of prostatitis","volume":"26","author":"Schaeffer","year":"2000","journal-title":"Brazilian Journal of Urology"},{"key":"10.1016\/j.amjmed.2005.05.008_bib8","first-page":"153","article-title":"Epidemiology of urinary tract infection","volume":"18","author":"Nicolle","year":"2001","journal-title":"Infect Med."},{"key":"10.1016\/j.amjmed.2005.05.008_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0891-5520(05)70373-1","article-title":"Diagnosis and treatment of uncomplicated urinary tract infection","volume":"11","author":"Hooton","year":"1997","journal-title":"Infect Dis Clin North Am."},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2005.05.008_bib10","first-page":"S46","article-title":"National guideline for the management of prostatitis","volume":"75","year":"1999","journal-title":"Sex Transm Infect."},{"key":"10.1016\/j.amjmed.2005.05.008_bib11","first-page":"34","article-title":"Confronting prostatitis","volume":"16","author":"Jack","year":"2004","journal-title":"Contemp Urol."},{"key":"10.1016\/j.amjmed.2005.05.008_bib12","first-page":"533","article-title":"UTIs in at-risk patients","volume":"16","author":"McCue","year":"1999","journal-title":"Infect Med."},{"key":"10.1016\/j.amjmed.2005.05.008_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2005.05.008_bib14","unstructured":"Trovan\u00ae (trovafloxacin) New Drug Application. US Food and Drug Administration Web site. Available at: http:\/\/www.fda.gov\/cder\/foi\/nda\/97\/020760a_medr_P6.pdf. Accessed October 13, 2004."},{"key":"10.1016\/j.amjmed.2005.05.008_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/423000","article-title":"A prospective, randomized trial of 3 of 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury","volume":"39","author":"Dow","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2005.05.008_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/14656566.4.5.693","article-title":"Best pharmacological practice","volume":"4","author":"Nicolle","year":"2003","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.amjmed.2005.05.008_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00042307-199901000-00010","article-title":"Short-term therapy of acute uncomplicated cystitis","volume":"9","author":"Naber","year":"1999","journal-title":"Curr Opin Urol."},{"key":"10.1016\/j.amjmed.2005.05.008_bib18","series-title":"The Sanford Guide to Antimicrobial Therapy","author":"Gilbert","year":"2004"},{"key":"10.1016\/j.amjmed.2005.05.008_bib19","series-title":"Data on file. The Surveillance Network (TSN) Database 2003","year":"2003"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2005.05.008_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections","volume":"183","author":"Stamm","year":"2001","journal-title":"J Infect Dis"},{"issue":"suppl 1A","key":"10.1016\/j.amjmed.2005.05.008_bib21","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1016\/S0002-9343(02)01058-6","article-title":"Urinary tract infection","volume":"113","author":"Nicolle","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2005.05.008_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/320880","article-title":"Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women","volume":"33","author":"Gupta","year":"2001","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2005.05.008_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0733-8627(05)70210-8","article-title":"Prostatitis","volume":"19","author":"Lummus","year":"2001","journal-title":"Emerg Med Clin North Am."},{"key":"10.1016\/j.amjmed.2005.05.008_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0090-4295(02)02300-2","article-title":"Antimicrobial therapy for bacterial and nonbacterial prostatitis","volume":"60","author":"Fowler","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2005.05.008_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.amjmed.2005.05.008_bib26","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"issue":"suppl S1","key":"10.1016\/j.amjmed.2005.05.008_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/dkf809","article-title":"Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections","volume":"50","author":"Nicolau","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2005.05.008_bib28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/archinte.164.15.1662","article-title":"Clinicians\u2019 perceptions of the problem of antimicrobial resistance in health care facilities","volume":"164","author":"Giblin","year":"2004","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjmed.2005.05.008_bib29","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.05.008_bib30","unstructured":"Data on file. Proceedings of the TRUST 8 (2004) Investigators\u2019 Meeting; May 25, 2004; New Orleans, LA. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2004."},{"key":"10.1016\/j.amjmed.2005.05.008_bib31","unstructured":"Data on file. Proceedings of the TRUST 7 (2002\u20132003) Surveillance Study. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2003."},{"key":"10.1016\/j.amjmed.2005.05.008_bib32","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1128\/AAC.45.5.1402-1406.2001","article-title":"Multidrug-resistant urinary tract isolates of Escherichia coli","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.amjmed.2005.05.008_bib33","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjmed.2005.05.008_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jac\/47.4.435","article-title":"In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae","volume":"47","author":"Zhanel","year":"2001","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.amjmed.2005.05.008_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/AAC.45.3.673-678.2001","article-title":"Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model","volume":"45","author":"Klepser","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"issue":"suppl 7A","key":"10.1016\/j.amjmed.2005.05.008_bib36","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/j.amjmed.2005.05.009","article-title":"Appropriate antibiotic treatment of genitourinary infections in hospitalized patients","volume":"118","author":"Liu","year":"2005","journal-title":"Am J Med."},{"key":"10.1016\/j.amjmed.2005.05.008_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkf046","article-title":"Patient compliance with antibiotic treatment for respiratory tract infections","volume":"49","author":"Kardas","year":"2002","journal-title":"J Antimicrob Chemother."},{"issue":"suppl 3","key":"10.1016\/j.amjmed.2005.05.008_bib38","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1086\/421354","article-title":"Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia","volume":"39","author":"File","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2005.05.008_bib39","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther."},{"key":"10.1016\/j.amjmed.2005.05.008_bib40","unstructured":"Levaquin [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc.; 2004."},{"key":"10.1016\/j.amjmed.2005.05.008_bib41","unstructured":"Cipro [package insert]. West Haven, CT: Bayer Pharmaceuticals Corporation; 2004."},{"key":"10.1016\/j.amjmed.2005.05.008_bib42","unstructured":"Tequin [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2004."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:38:25Z","timestamp":1757579905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0002934305003827"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.05.008","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational antibiotic treatment of outpatient genitourinary infections in a changing environment","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}